Understanding Cardiovascular Risk, Bone Density, Lifestyle Medicine, and Hormone Therapy During the Menopausal Transition
May is nationally recognized as Women’s Health Month, Osteoporosis Awareness Month, High Blood Pressure Education Month, Arthritis Awareness Month, Stroke Awareness Month, and Physical Fitness & Sports Month — all observances that closely connect to one of the most important and rapidly evolving areas in internal medicine today: perimenopause.
Perimenopause is no longer viewed as simply a reproductive transition. Emerging research increasingly shows that the hormonal shifts occurring during perimenopause affect nearly every major system in the body, including cardiovascular health, bone density, metabolism, cognition, sleep, inflammation, and musculoskeletal health.
At Alpharetta & Cumming Internal Medicine, preventive internal medicine care focuses on helping women throughout Alpharetta, Cumming, Roswell, and North Fulton navigate these changes with evidence-based guidance, individualized risk assessment, and long-term health planning.
What Is Perimenopause?
Perimenopause refers to the transitional years leading up to menopause, when ovarian hormone production becomes increasingly inconsistent. While menopause is officially defined as 12 consecutive months without a menstrual cycle, hormonal fluctuations can begin many years earlier.
Most women enter perimenopause during their 40s, though symptoms may begin earlier.
Common symptoms include:
- Hot flashes
- Night sweats
- Sleep disruption
- Anxiety or mood changes
- Brain fog
- Fatigue
- Weight redistribution
- Joint pain
- Irregular menstrual cycles
- Reduced exercise recovery
- Vaginal dryness
- Changes in libido
Research now suggests these symptoms are not isolated inconveniences. Many reflect broader physiologic changes occurring throughout the body during declining estrogen exposure.
Why Perimenopause Matters for Cardiovascular Health
Cardiovascular disease remains the leading cause of death among women in the United States. Historically, however, menopause and cardiovascular risk were often discussed separately.
Newer research increasingly connects the two.
Estrogen appears to play a protective role in vascular function, cholesterol regulation, and metabolic health. As estrogen levels decline during perimenopause and menopause, women experience increasing rates of:
- Hypertension
- Elevated LDL cholesterol
- Central weight gain
- Insulin resistance
- Vascular inflammation
- Sleep disruption
- Cardiovascular disease
Recent studies have shown that earlier menopause may significantly increase long-term cardiovascular risk. One large analysis found women who experienced menopause before age 40 had approximately a 40% higher lifetime risk of coronary heart disease.
Researchers are also increasingly examining how untreated menopause symptoms indirectly affect cardiovascular health. Chronic sleep disruption, fatigue, stress, reduced physical activity, and metabolic changes may all contribute to worsening long-term outcomes.
For this reason, blood pressure monitoring, cholesterol screening, diabetes evaluation, and lifestyle counseling have become increasingly important components of midlife women’s healthcare.
The Shift in Hormone Therapy Research
Hormone therapy remains one of the most discussed topics in women’s health.
For years, many women and physicians avoided menopausal hormone therapy following early interpretations of the Women’s Health Initiative (WHI) studies in the early 2000s. More recent analyses, however, have led many menopause experts to re-evaluate those concerns — particularly for healthy women in early menopause without contraindications.
Current evidence increasingly suggests that:
- Hormone therapy remains the most effective treatment for moderate-to-severe hot flashes and night sweats
- Timing appears to matter significantly
- Women who begin therapy earlier in menopause may have different risk profiles than women who begin treatment later in life
- Hormone therapy may offer benefits related to bone density preservation and quality of life in appropriately selected patients
Recent reviews and expert panels have noted potential associations between hormone therapy and:
- Improved bone density
- Reduced fracture risk
- Improved vascular markers
- Better symptom control
- Possible cognitive and cardiovascular benefits in younger menopausal women without major cardiovascular disease risk factors.
At the same time, experts continue to emphasize that hormone therapy is not appropriate for every patient. Individual risk factors, including personal history of clotting disorders, certain cancers, stroke, and cardiovascular disease, must still be carefully evaluated.
The modern approach to menopause care increasingly focuses on individualized decision-making rather than broad universal recommendations.
Bone Density Loss Often Begins Earlier Than Women Realize
Bone density decline frequently accelerates during the menopausal transition due to decreasing estrogen levels.
Research continues to show that women can lose substantial bone mass during the years surrounding menopause, increasing the future risk of:
- Osteopenia
- Osteoporosis
- Hip fractures
- Vertebral fractures
- Loss of mobility
Current research strongly supports the importance of resistance training and weight-bearing exercise during perimenopause and postmenopause. Exercise not only supports cardiovascular health, but also stimulates bone remodeling and muscle preservation.
Emerging evidence suggests that combining structured exercise with appropriately selected hormone therapy may provide the greatest protective effect on bone mineral density for some women.
Internal medicine physicians may recommend:
- Bone density screening (DEXA scans)
- Vitamin D evaluation
- Calcium optimization
- Resistance training
- Fall prevention strategies
- Nutritional counseling
- Osteoporosis treatment when appropriate
Perimenopause and Arthritis-Like Symptoms
Many women report worsening joint pain, stiffness, and musculoskeletal discomfort during perimenopause.
Researchers increasingly believe hormonal changes may contribute to inflammatory responses affecting joint tissues, muscle recovery, and pain perception. While osteoarthritis risk naturally increases with age, declining estrogen may also influence symptom severity in some women.
Maintaining muscle mass becomes especially important during midlife, as women naturally begin to lose lean muscle tissue during the menopausal transition.
Strength training is now widely recommended not only for fitness, but also for:
- Bone density preservation
- Joint stabilization
- Fall prevention
- Metabolic health
- Glucose regulation
- Long-term mobility
Lifestyle Medicine Is Becoming Central to Menopause Care
One of the clearest themes emerging from recent menopause research is that lifestyle medicine plays a major role in long-term outcomes.
Current evidence increasingly supports:
- Resistance training several times weekly
- Regular cardiovascular exercise
- DASH-style nutrition patterns
- Sleep optimization
- Stress reduction
- Weight management
- Smoking cessation
- Alcohol moderation
The International Menopause Society recently emphasized that regular exercise improves:
- Bone health
- Muscle strength
- Cardiovascular health
- Fall prevention
- Overall mortality risk in midlife women.
Lifestyle interventions may also help reduce:
- Insulin resistance
- Visceral fat accumulation
- Blood pressure elevations
- Sleep disruption
- Mood instability
Importantly, experts increasingly emphasize that women do not need extreme fitness routines to improve health outcomes. Sustainable consistency appears far more important than intensity.
A More Comprehensive Understanding of Women’s Midlife Health
Perimenopause is increasingly recognized as a major physiologic transition rather than simply the end of reproductive years.
Researchers continue to explore how hormonal changes affect:
- Cardiovascular health
- Brain aging
- Bone metabolism
- Inflammation
- Sleep quality
- Cognitive function
- Muscle preservation
- Metabolic disease risk
As awareness grows, more women are seeking evidence-based preventive care and individualized discussions surrounding symptom management, cardiovascular screening, bone health, and lifestyle medicine.
At Alpharetta & Cumming Internal Medicine, comprehensive preventive care helps women throughout Alpharetta, Roswell, Cumming, and Forsyth County better understand the changes occurring during perimenopause and menopause while supporting long-term health through screening, education, and personalized treatment planning.
To schedule an appointment with one of our Board-Certified internists, please call (770) 475-2377 or conveniently request an appointment via our ‘Contact Us’ form at the bottom of our homepage.
